Abbott Announces Phase 3 Hepatitis C Program Details

[at noodls] – Abbott Park, Illinois (NYSE: ABT) – Abbott today released details on its phase 3 hepatitis C registrational program following promising results from its phase 2b clinical trial, known as Aviator, presented … more

View todays social media effects on ABT

View the latest stocks trending across Twitter. Click to view dashboard